BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33014831)

  • 61. MicroRNA-194 inhibits cell invasion and migration in hepatocellular carcinoma through PRC1-mediated inhibition of Wnt/β-catenin signaling pathway.
    Tang H; Zhao H; Yu ZY; Feng X; Fu BS; Qiu CH; Zhang JW
    Dig Liver Dis; 2019 Sep; 51(9):1314-1322. PubMed ID: 30948333
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Interaction Between Long Non-coding RNA HULC and MicroRNA-622 via Transfer by Extracellular Vesicles Regulates Cell Invasion and Migration in Human Pancreatic Cancer.
    Takahashi K; Koyama K; Ota Y; Iwamoto H; Yamakita K; Fujii S; Kitano Y
    Front Oncol; 2020; 10():1013. PubMed ID: 32656089
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Overexpression of microRNA-194 suppresses the epithelial-mesenchymal transition in targeting stem cell transcription factor Sox3 in endometrial carcinoma stem cells.
    Gong B; Yue Y; Wang R; Zhang Y; Jin Q; Zhou X
    Tumour Biol; 2017 Jun; 39(6):1010428317706217. PubMed ID: 28618953
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
    Kong X; Ding X; Li X; Gao S; Yang Q
    Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 cooperates with enhancer of zeste homolog 2 to promote hepatocellular carcinoma development by modulating the microRNA-22/Snail family transcriptional repressor 1 axis.
    Chen S; Wang G; Tao K; Cai K; Wu K; Ye L; Bai J; Yin Y; Wang J; Shuai X; Gao J; Pu J; Li H
    Cancer Sci; 2020 May; 111(5):1582-1595. PubMed ID: 32129914
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Fusion of macrophages promotes breast cancer cell proliferation, migration and invasion through activating epithelial-mesenchymal transition and Wnt/β-catenin signaling pathway.
    Zhang LN; Huang YH; Zhao L
    Arch Biochem Biophys; 2019 Nov; 676():108137. PubMed ID: 31605677
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MicroRNA-150 suppresses epithelial-mesenchymal transition, invasion, and metastasis in prostate cancer through the TRPM4-mediated β-catenin signaling pathway.
    Hong X; Yu JJ
    Am J Physiol Cell Physiol; 2019 Apr; 316(4):C463-C480. PubMed ID: 30566393
    [TBL] [Abstract][Full Text] [Related]  

  • 68. miR-33b-3p Acts as a Tumor Suppressor by Targeting
    Mei Y; Li K; Zhang Z; Li M; Yang H; Wang H; Huang X; Li X; Shi S; Yang H
    Front Oncol; 2021; 11():740452. PubMed ID: 34804930
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epigenetic Regulation of EMT (Epithelial to Mesenchymal Transition) and Tumor Aggressiveness: A View on Paradoxical Roles of KDM6B and EZH2.
    Lachat C; Boyer-Guittaut M; Peixoto P; Hervouet E
    Epigenomes; 2018 Dec; 3(1):. PubMed ID: 34991274
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Targeted intervention of eIF4A1 inhibits EMT and metastasis of pancreatic cancer cells via c-MYC/miR-9 signaling.
    Zhao Y; Wang Y; Chen W; Bai S; Peng W; Zheng M; Yang Y; Cheng B; Luan Z
    Cancer Cell Int; 2021 Dec; 21(1):670. PubMed ID: 34906136
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A statin-regulated microRNA represses human c-Myc expression and function.
    Takwi AA; Li Y; Becker Buscaglia LE; Zhang J; Choudhury S; Park AK; Liu M; Young KH; Park WY; Martin RC; Li Y
    EMBO Mol Med; 2012 Sep; 4(9):896-909. PubMed ID: 22887866
    [TBL] [Abstract][Full Text] [Related]  

  • 72. INPP4B suppresses HER2-induced mesenchymal transition in HER2+ breast cancer and enhances sensitivity to Lapatinib.
    Qu N; Wang G; Su Y; Chen B; Zhou D; Wu Y; Yuan L; Yin M; Liu M; Peng Y; Zhou W
    Biochem Pharmacol; 2024 Jun; 226():116347. PubMed ID: 38852646
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Diosgenin and GSK126 Produce Synergistic Effects on Epithelial-Mesenchymal Transition in Gastric Cancer Cells by Mediating EZH2 via the Rho/ROCK Signaling Pathway.
    Liu S; Rong G; Li X; Geng L; Zeng Z; Jiang D; Yang J; Wei Y
    Onco Targets Ther; 2020; 13():5057-5067. PubMed ID: 32606728
    [TBL] [Abstract][Full Text] [Related]  

  • 74. LncRNA SNHG6 sponges miR-101 and induces tamoxifen resistance in breast cancer cells through induction of EMT.
    Khan MI; Ahmad A
    Front Oncol; 2022; 12():1015428. PubMed ID: 36212408
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MicroRNA-365 targets multiple oncogenes to inhibit proliferation, invasion, and self-renewal of aggressive endometrial cancer cells.
    Wang C; Su K; Zhang Y; Zhang W; Chu D; Zhao Q; Guo R
    Cancer Manag Res; 2018; 10():5171-5185. PubMed ID: 30464615
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Epigenetic Silencing of miR-33b Promotes Peritoneal Metastases of Ovarian Cancer by Modulating the TAK1/FASN/CPT1A/NF-κB Axis.
    Wang X; Yung MMH; Sharma R; Chen F; Poon YT; Lam WY; Li B; Ngan HYS; Chan KKL; Chan DW
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638280
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Analyses of publicly available genomics resources define FGF-2-expressing bladder carcinomas as EMT-prone, proliferative tumors with low mutation rates and high expression of CTLA-4, PD-1 and PD-L1.
    McNiel EA; Tsichlis PN
    Signal Transduct Target Ther; 2017; 2():16045-. PubMed ID: 28515962
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Polyploidy, EZH2 upregulation, and transformation in cytomegalovirus-infected human ovarian epithelial cells.
    El Baba R; Haidar Ahmad S; Monnien F; Mansar R; Bibeau F; Herbein G
    Oncogene; 2023 Oct; 42(41):3047-3061. PubMed ID: 37634008
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lipogenic gene expression profile in patients with gastric cancer.
    Miyachi K; Sawada Y; Shida Y; Sugawara A; Hisatomi H
    Mol Clin Oncol; 2013 Sep; 1(5):825-827. PubMed ID: 24649254
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Retraction: MicroRNA-33b Suppresses Migration and Invasion by Targeting c-Myc in Osteosarcoma Cells.
    PLOS ONE Editors
    PLoS One; 2022; 17(6):e0269899. PubMed ID: 35675351
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.